The buy thesis
Omega Healthcare (NYSE:OHI) has been traded with the rest of the healthcare sector, completely independent of its fundamentals as an individual company. After years of consistent FFO/share growth and dividend growth, its intrinsic value now greatly exceeds that implied by its market price. It is trading at only 10.7X projected 2016 FFO; a multiple which does not make sense for a strong, conservatively levered and growing company. Before we get into a fundamental demonstration of its mispricing, I would like to spend a fair bit of time going over how such mispricing came about.
Origin of mispricing
There are plenty of excellent companies to invest in, but most are only available at the expensive pricing...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|